In Vitro and in Vivo Vasodilatory Activity of barnidipine and Its Enantiomers
スポンサーリンク
概要
- 論文の詳細を見る
Barnidipine, (3'S)-1-benzyl-3-pyrrolidinyl methyl (4S)-2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, is a dihydropyridine calcium antagonist with asymmetric carbons at the dihydropyridine C-4 and the pyrrolidine C-3' positions. In this study, the vasodilatory activity of barnidipine and its 3 optical isomers were compared in vitro and in vivo to assess the steric effects of these asymmetric carbons. All these enantiomers produced concentration-dependent relaxation on KCl (40 mM)-induced contractions in isolated guinea pig aorta with a potency order of barnidipine>(3'R, 4R)≅(3'R, 4S)>(3'S, 4R). The potency ratio between barnidipine and the (3'S, 4R) enantiomer was 118. All enantiomers increased coronary blood flow after intra-arterial administration to aneshetized coronary-perfused dogs. The potency order almost agreed with that obtained in vitro, although the potency ratio between barnidipine and the (3'S, 4R) enantiomer was only 15. These 4 enantiomers showed stereoselectivity for time couse shanges as well. The onset and disappearance of blood flow increase after intracoronary administration of barnidipine were slower than those of other enantiomers. The duration for barnidipine was longer than those for other dihydropyridine calcium antagonists such as nifedipine or nitrendipine. The present study suggests stereoselectivity for the C-4 dihydropyridine and to a lesser degree for the C-3' of pyrrolidine in an ester moiety. The steric effects of these carbons were observed not only in the potency of vasodilatory activity but also in its duration.
- 公益社団法人日本薬学会の論文
- 1999-02-15
著者
-
Asano M
Department Of Pharmacology Nagoya City University Medical School
-
Inagaki Osamu
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co.
-
Asano Masaharu
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Takenaka T
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Takenaka Toichi
Institute For Drug Discovery Research Yamanouchi Pharmaceutical
関連論文
- FLAVOSTATIN, A NOVEL DISINTEGRIN FROM THE VENOM OF "HABU" (TRIMERESURUS FLAVOVIRIDIS)
- Studies on Cardiac Ingredients of Plants. XIII : Chemical Modification of Gitoxin to Cardiotonic Compounds without Vascular Contractile Effect
- Novel Potassium Channel Activators : Synthesis and Structure-Activity Relationship Studies of 3,4-Dihydro-2H-1,4-benzoxazine Derivatives
- Studies on Nonpeptide Angiotensin II Receptor Antagonists. IV. Synthesis and Biological Evaluation of 4-Acrylamide-1H-imidazole Derivatives
- Studies on Nonpeptide Angiotensin II Receptor Antagonists. III. Synthesis and Biological Evaluation of 5-Alkylidene-3,5-dihydro-4H-imidazol-4-one-Derivatives
- Studies on Nonpeptide Angiotensin II Receptor Antagonists. II. Synthesis and Biological Evaluation of 5H-Pyrazolo[1,5-b][1,2,4]triazole Derivatives with a C-Linked Oxygen Functional Group at the 6-Position
- Studies no Nonpeptide Angiotensin II Receptor Antagonists. I. Synthesis and Biological Evaluation of Pyrazolo[1,5-b][1,2,4]triazole Derivatives with Alkyl Substituents
- Cardiovascular Effects of YM430,a 1,4-Dihydropyridine Derivative with β-Adrenoceptor Blocking Activity, in Dogs and Rats
- Comparison between YM099 and Captopril in Rats with Renal Mass Reduction-Induced Progressive Renal Disease(Pharmacology)
- Hypotensive Effects of YM430, a 1 ,4 : Dihydropyridine Derivative, in Spontaneously Hypertensive Rats and Renal Hypertensive Dogs
- Effects of YM358,an Angiotensin II Type 1 (AT_1) Receptor Antagonist, and Enalapril on Blood Pressure and Vasoconstriction in Two Renal Hypertension Models
- In Vitro and in Vivo Vasodilatory Activity of barnidipine and Its Enantiomers
- Effects of Angiotensin II Type 1 Receptor Antagonist, YM358, on Cardiac Hypertrophy and Dysfunction after Myocardial Infarction in Rats
- Comparison of the Angiotensin II Type 1-Receptor Antagonist YM358 and the Angiotensin-Converting Enzyme Inhibitor Enalapril in Rats With Cardiac Volume Overload
- Antihypertensive Effect of YM730, A New Calcium Antagonist, in Stroke-prone Spontaneously Hypertensive Rats